Until recently, most physicians believed that LowB1 was uncommon. But the impressive and frequent success that has been recently achieved by physicians with the use of a high-potency bioactive form of Vitamin B1 on their patients suffering from the most common signs of LowB1–numbness, tingling, burning, and pains in the feet and legs–has convinced many physicians that LowB1 is far more common than previously thought.
We are currently at the early stages of a growing awareness by physicians in the US as to the extent that LowB1 impacts the population in general and diabetics, prediabetics, alcoholics, the elderly and the obese in particular.